Reactive aldehydes: an initial path to develop precision medicine for pain control

Vanessa O Zambelli1, Che-Hong Chen1, Eric R Gross1

  • 11 Laboratory of Pain and Signaling, Butantan Institute, São Paulo 05503-900, Brazil ; 2 Department of Chemical and Systems Biology, 3 Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Insights

Reactive aldehydes contribute to pain sensation. Mitochondrial aldehyde dehydrogenase 2 (ALDH2) metabolism of these aldehydes offers a target for pain management, especially for individuals with the ALDH2*2 variant.

Area of Science:

  • Biochemistry
  • Pain research
  • Pharmacology

Background:

  • Opioid-related risks necessitate novel pain treatment targets.
  • Reactive aldehydes are implicated in pain signaling pathways.
  • Mitochondrial aldehyde dehydrogenase 2 (ALDH2) plays a role in aldehyde metabolism.

Purpose of the Study:

  • To explore the role of reactive aldehydes in pain.
  • To investigate the function of ALDH2 in regulating inflammatory pain.
  • To discuss the clinical implications of ALDH2 variants in pain management.

Main Methods:

  • Literature review and discussion in response to an editorial.
  • Analysis of reactive aldehyde production and metabolism in pain.
  • Examination of ALDH2 enzyme activity and its impact on pain.

Main Results:

  • Reactive aldehyde production can initiate pain signaling.
  • ALDH2 efficiently metabolizes reactive aldehydes, mitigating inflammatory pain.
  • Inefficient metabolism due to ALDH2*2 variant affects approximately 540 million people.

Conclusions:

  • Targeting ALDH2 offers a potential therapeutic strategy for pain control.
  • ALDH2-targeted therapeutics could lead to precision medicine for pain.
  • Understanding ALDH2's role is crucial for developing non-addictive pain treatments.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.9K
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
728
Oxidations of Aldehydes and Ketones to Carboxylic Acids01:15

Oxidations of Aldehydes and Ketones to Carboxylic Acids

Oxidation of aldehydes and ketones results in the formation of carboxylic acids. Aldehydes, bearing hydrogen next to the carbonyl group, are easily oxidized compared to ketones. This is because an aldehydic proton can easily be abstracted during oxidation.
Aldehydes readily undergo oxidation in strong oxidizing agents such as potassium permanganate and chromic acid. The oxidation can also be carried out using mild oxidizing agents such as silver oxide. In fact, aldehydes can be easily oxidized...
6.7K
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
13.1K
Preparation of Aldehydes and Ketones from Carboxylic Acid Derivatives01:18

Preparation of Aldehydes and Ketones from Carboxylic Acid Derivatives

Aldehydes are more reactive than carboxylic acids and hence, can get over-reduced to alcohol in the presence of strong reducing agents. Therefore, carboxylic acids are inefficient in preparing aldehydes using LAH.
Carboxylic acid derivatives like acid chlorides and esters are more easily reducible than the corresponding acids. The derivatives reduce in the presence of mild reducing agents to give aldehydes. Aldehydes can also be prepared by Rosenmund reduction, that is, the reduction of...
3.8K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K